Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial

Nikhil Patel

Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial

Nikhil Patel

Clinical Pathology

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Medicine
State	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{a411b27579644709b5a85cbc5116c755,

title = "Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial",

author = "Nikhil Patel",

year = "2004",

language = "Undefined",

journal = "Medicine",

issn = "1357-3039",

publisher = "Elsevier Ltd",

}